LIPSIA-STRATEGY trial demonstrates non-inferiority of CAAS vFFR guided revascularization against pressure wire-based FFR revascularization
MAASTRICHT, Netherlands, Nov. 3, 2026 /PRNewswire/ — Pie Medical Imaging, a global leader in cardiovascular image analysis solutions, announces the results of the LIPSIA-STRATEGY trial, presented during the Late-Breaking Clinical Trials session

